Human Molecular Genetics Advance Access published online on August 4, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi295
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departments of Ophthalmology, 832 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
* To whom correspondence should be addressed. The FOX family of transcription factor genes is an evolutionary conserved, yet functionally diverse class of transcription factors that are important for regulation of energy homeostasis, development and oncogenesis. The proteins encoded by FOX genes are characterized by a conserved DNA-binding domain known as the Forkhead domain. To date disease-causing mutations have been identified in eight human FOX genes. Many of these mutations result in single amino acid substitutions in the Forkhead domain. We analyzed the molecular consequences of two disease-causing missense mutations (R121H and S125L) occurring in the Forkhead domain of the FOXC2 gene that were identified in patients with hereditary lymphedema with distichiasis to test the predictive capacity of a forkhead domain structure/function model. Based on the FOXC2 solution structure, both FOXC2 missense mutations are located on the DNA-recognition helix of the forkhead domain. A mutation model based on the parologous FOXC1 protein predicts that these FOXC2 missense mutations will impair the DNA-binding and transcriptional activation ability of the FOXC2 protein. When these mutations were analyzed biochemically, we found that both mutations did indeed reduce the DNA-binding and transcriptional capacity. In addition the R121H mutation affected nuclear localization of FOXC2. Together these data indicate that these FOXC2 missense mutations are functional nulls, that FOXC2 haploinsufficiency underlies hereditary lymphedema with distichiasis, and validates the predictive ability of the FOXC1-based Forkhead domain mutational model.
Received June 8, 2005
Revised July 28, 2005
Accepted July 28, 2005
Article
The establishment of a predictive mutational model of the Forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis
2 Medical Genetics, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
3 Departments of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
4 Departments of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7; Medical Genetics, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
Fred B. Berry, E-mail: fberry{at}ualberta.ca
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Dipietromaria, B. A. Benayoun, A.-L. Todeschini, I. Rivals, C. Bazin, and R. A. Veitia Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems Hum. Mol. Genet., September 1, 2009; 18(17): 3324 - 3333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, J. Chi, F. B. Berry, T. K. Footz, M. W. Sharp, and M. A. Walter Human p32 Is a Novel FOXC1-Interacting Protein That Regulates FOXC1 Transcriptional Activity in Ocular Cells Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5243 - 5249. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Beysen, L. Moumne, R. Veitia, H. Peters, B. P. Leroy, A. De Paepe, and E. De Baere Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation Hum. Mol. Genet., July 1, 2008; 17(13): 2030 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Mellor, G. Brice, A. W.B. Stanton, J. French, A. Smith, S. Jeffery, J. R. Levick, K. G. Burnand, and P. S. Mortimer Mutations in FOXC2 Are Strongly Associated With Primary Valve Failure in Veins of the Lower Limb Circulation, April 10, 2007; 115(14): 1912 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Ito, T. K. Footz, T. C. Murphy, W. Courtens, and M. A. Walter Analyses of a Novel L130F Missense Mutation in FOXC1 Arch Ophthalmol, January 1, 2007; 125(1): 128 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Vernes, J. Nicod, F. M. Elahi, J. A. Coventry, N. Kenny, A.-M. Coupe, L. E. Bird, K. E. Davies, and S. E. Fisher Functional genetic analysis of mutations implicated in a human speech and language disorder Hum. Mol. Genet., November 1, 2006; 15(21): 3154 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Berry, M. A. Lines, J. M. Oas, T. Footz, D. A. Underhill, P. J. Gage, and M. A. Walter Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis Hum. Mol. Genet., March 15, 2006; 15(6): 905 - 919. [Abstract] [Full Text] [PDF] |
||||



